We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $453M
1-Year Est. Return 20.63%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.63%
3 Year Est. Return
+53.69%
5 Year Est. Return
+69.59%
10 Year Est. Return
+264.58%
AUM
$458M
AUM Growth
+$34.2M
Cap. Flow
+$4.31M
Cap. Flow %
0.94%
Top 10 Hldgs %
29.78%
Holding
122
New
5
Increased
30
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$2.66M
2
INDB icon
Independent Bank
INDB
+$1.16M
3
PG icon
Procter & Gamble
PG
+$695K
4
ADBE icon
Adobe
ADBE
+$262K
5
WEC icon
WEC Energy
WEC
+$206K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.15%
2 Technology 15.13%
3 Healthcare 11.15%
4 Financials 10.59%
5 Consumer Staples 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.71T
$21.5M 4.7%
41,547
+47
+0.1% +$24K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$875B
$19.7M 4.31%
29,431
-193
-0.7% -$124K
AAPL icon
3
Apple
AAPL
$4.67T
$14.8M 3.24%
58,139
+696
+1% +$157K
WMT icon
4
Walmart Inc
WMT
$850B
$13.3M 2.9%
128,921
-540
-0.4% -$53.8K
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.14T
$12.4M 2.7%
50,830
-1,283
-2% -$269K
ABBV icon
6
AbbVie
ABBV
$453B
$11.8M 2.59%
51,138
-148
-0.3% -$30.1K
MA icon
7
Mastercard
MA
$507B
$11.6M 2.54%
20,427
-89
-0.4% -$51.1K
JPM icon
8
JPMorgan Chase
JPM
$953B
$10.9M 2.38%
34,535
-554
-2% -$165K
FAST icon
9
Fastenal
FAST
$56.9B
$10.3M 2.25%
209,717
-2,085
-1% -$98.5K
TSCO icon
10
Tractor Supply
TSCO
$18.2B
$9.95M 2.17%
174,985
-1,595
-0.9% -$94K
CSCO icon
11
Cisco
CSCO
$431B
$9.9M 2.16%
144,705
-424
-0.3% -$28.9K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.08T
$9.56M 2.09%
19,006
+11
+0.1% +$5.33K
XYL icon
13
Xylem
XYL
$24.7B
$9.54M 2.08%
64,674
-278
-0.4% -$38.6K
BNY
14
Bank of New York Mellon
BNY
$112B
$9.18M 2.01%
84,262
-2,427
-3% -$248K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$110B
$9.05M 1.98%
76,138
-122
-0.2% -$14K
ABT icon
16
Abbott
ABT
$187B
$7.95M 1.74%
59,338
+635
+1% +$83.4K
AMZN icon
17
Amazon
AMZN
$2.79T
$7.85M 1.72%
35,772
+897
+3% +$203K
MCD icon
18
McDonald's
MCD
$181B
$7.6M 1.66%
25,020
-128
-0.5% -$39K
PG icon
19
Procter & Gamble
PG
$340B
$7.59M 1.66%
49,426
+4,449
+10% +$695K
LIN icon
20
Linde
LIN
$220B
$7.57M 1.66%
15,942
+18
+0.1% +$8.52K
NVDA icon
21
NVIDIA
NVDA
$5.56T
$7.53M 1.65%
40,349
+969
+2% +$169K
DHI icon
22
D.R. Horton
DHI
$39.9B
$7.18M 1.57%
42,392
-130
-0.3% -$20.4K
IEMG icon
23
iShares Core MSCI Emerging Markets ETF
IEMG
$165B
$7.05M 1.54%
107,002
-175
-0.2% -$10.9K
LH icon
24
Labcorp
LH
$26.5B
$6.93M 1.51%
24,142
-79
-0.3% -$21.2K
SNA icon
25
Snap-on
SNA
$19.8B
$6.56M 1.43%
18,942
-25
-0.1% -$8.18K

Similar funds

Boston Research & Management's Q3 2025 Portfolio in Review

As of Q3 2025, Boston Research & Management held 122 positions worth $458M, up 8.1% from $423M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Boston Research & Management's Q3 2025 filing shows 5 new, 30 increased, 36 reduced and 2 closed positions. Its largest new stake was Equinix: 3,402 shares worth $2.66M. The largest sale was Albemarle Corp Depositary Shares, an estimated $505K.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Boston Research & Management's largest Q3 2025 buy was Equinix: 3,402 shares worth $2.66M.
  • Boston Research & Management added most to Procter & Gamble in Q3 2025, an estimated $695K increase.
  • Boston Research & Management's biggest Q3 2025 reduction was Albemarle Corp Depositary Shares, cutting an estimated $505K.
  • Boston Research & Management fully exited Worthington Enterprises in Q3 2025, selling an estimated $223K.
  • Boston Research & Management's ten largest holdings make up 30% of its $458M portfolio in Q3 2025.
  • Boston Research & Management opened 5 new positions and closed 2 in Q3 2025.
  • Boston Research & Management's portfolio value rose 8.1% quarter-over-quarter to $458M.

Based on Boston Research & Management's 13F filing for Q3 2025, filed 12 Nov 2025.